Prophylactic TxA administration in patients undergoing major gastrointestinal surgery reduces the incidence of delirium after surgery when compared with placebo. The unifying hypothesis is that systemic and neuro-inflammation lead to neuronal injury and resultant postoperative delirium.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
incidence of delirium in the first 3 days postoperatively
Timeframe: post surgical incision to day 3 (at anytime)obtaining information from the patient, family and staff, and thorough chart review